Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1966; Volume 2,Issue 6

Articles

  • You have access
    Blockade of Norepinephrine-Induced Lipolysis by Isomers of dl-1-(Nitrophenyl)-1-Hydroxy-2-Isopropylaminoethane
    JOHN J. LECH, PITAMBAR SOMANI and DEANE N. CALVERT
    Molecular Pharmacology November 1966, 2 (6) 501-505;
  • You have access
    Further Studies on the Stimulation of L-(14C)-Amino Acid Incorporation with Cycloheximide
    W. R. JONDORF, D. C. SIMON and M. AVNIMELECH
    Molecular Pharmacology November 1966, 2 (6) 506-517;
  • You have access
    Modifying Effects of Anions on the Alkali-Cation-Activated AMP Deaminase of Human Erythrocyte
    AMIR ASKARI
    Molecular Pharmacology November 1966, 2 (6) 518-525;
  • You have access
    The Mechanism of the Inhibition of Aminotransferases by Salicylate
    B. J. GOULD, P. D. DAWKINS, M. J. H. SMITH and A. J. LAWRENCE
    Molecular Pharmacology November 1966, 2 (6) 526-533;
  • You have access
    Inhibition of Protein and RNA Synthesis in HeLa Cells by Levallorphan and Levorphanol
    WILLIAM D. NOTEBOOM and GERALD C. MUELLER
    Molecular Pharmacology November 1966, 2 (6) 534-542;
  • You have access
    Synthesis of Ribonucleic Acid in L Cells during Inhibition of Protein Synthesis by Cycloheximide
    HERBERT L. ENNIS
    Molecular Pharmacology November 1966, 2 (6) 543-557;
  • You have access
    Fluoride Inhibition of Acetylcholinesterase
    R. M. KRUPKA
    Molecular Pharmacology November 1966, 2 (6) 558-569;
  • You have access
    Studies on Depurination and Alkylation of DNA’s of Different Base Compositions
    STEPHEN ZAMENHOF and SHIGEYO ARIKAWA
    Molecular Pharmacology November 1966, 2 (6) 570-573;
  • You have access
    Studies on Adenosine Deaminase
    MARGARET ROCKWELL and M. HELEN MAGUIRE
    Molecular Pharmacology November 1966, 2 (6) 574-584;
  • You have access
    Chemical Methylation of Synthetic Polynucleotides
    DAVID B. LUDLUM
    Molecular Pharmacology November 1966, 2 (6) 585-592;
  • You have access
    The Reaction of Carbamates with Cholinesterase
    R. D. O’BRIEN, B. D. HILTON and L. GILMOUR
    Molecular Pharmacology November 1966, 2 (6) 593-605;
  • You have access
    The Effect of Reserpine on Growth and Catecholamine Content of Tetrahymena
    J. J. BLUM, N. KIRSHNER and J. UTLEY
    Molecular Pharmacology November 1966, 2 (6) 606-608;
  • You have access
    Formation of a Dead Code Triplet through Replacement of the Terminal Ribonucleoside in Guanylyl-Uridylyl-Uridine and Guanylyl-Uridylyl-Cytidine by 6-Azacytidine
    J. ŠKODA, V. LISÝ, J. SMRT, A. HOLÝ and F. ŠORM
    Molecular Pharmacology November 1966, 2 (6) 608-610;
  • You have access
    Increased Synthesis of Norepinephrine in the Rat Heart on Electrical Stimulation of the Stellate Ganglia
    ROBERT GORDON, JOHN V. O. REID, ALBERT SJOERDSMA and SIDNEY UDENFRIEND
    Molecular Pharmacology November 1966, 2 (6) 610-613;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 2, Issue 6
1 Nov 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics